Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study

Kimberly Daniels; Stephan Lanes; Arlene Tave; Michael Pollack; David Mannino; Gerard Criner; Amanda Neikirk; Kirsty Rhodes; Norbert Feigler; Clementine Nordon

doi:10.2147/copd.s438893

journal article Open Access Jan 01, 2024

Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study

Kimberly Daniels

Stephan Lanes Arlene Tave Michael Pollack

David Mannino Gerard Criner Amanda Neikirk Kirsty Rhodes Norbert Feigler Clementine Nordon

International Journal of Chronic Obstructive Pulmonary Disease Vol. Volume 19 pp. 225-241 · Informa UK Limited

View at Publisher Save 10.2147/copd.s438893

Topics

No keywords indexed for this article. Browse by subject →

References

41

[1]

Hacker K. COPD Death Rates in the United States. Centers for disease control and prevention. Chronic Obstructive Pulmonary Disease (COPD) Web site; 2021. Available from: https://www.cdc.gov/copd/data.html. Accessed October 18, 2021.

[2]

DeBolt Yale J Biol Med (2021) 10.1111/joac.12104

[3]

Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease

Nermin Diab, Andrea S. Gershon, Don D. Sin et al.

American Review of Respiratory Disease 2018 10.1164/rccm.201804-0621ci

[4]

Martinez Ann Am Thorac Soc (2015) 10.1513/annalsats.201506-388oc

[5]

Claxton Npj Digital Med (2021) 10.1038/s41746-021-00472-x

[6]

MacIntyre Proc Am Thorac Soc (2008) 10.1513/pats.200707-088et

[7]

Connors Am J Respir Crit Care Med (1996) 10.1164/ajrccm.154.4.8887592

[8]

Donaldson Thorax (2006) 10.1136/thx.2005.041806

[9]

Whittaker Int J Chronic Obstr (2022) 10.2147/copd.s346591

[10]

Martinez Am J Respir Crit Care Med (2021) 10.1164/rccm.202006-2618oc

[11]

Mullerova Ther Adv Respir Dis (2022) 10.1177/17534666221113647

[12]

Terzano Lung (2010) 10.1007/s00408-009-9222-y

[13]

Chenna Semin Respir Crit Care Med (2010) 10.1055/s-0030-1254069

[14]

Dransfield J Am Heart Assoc (2022) 10.1161/jaha.121.024350

[15]

Fu PLoS One (2021) 10.1371/journal.pone.0256480

[16]

Suissa Thorax (2012) 10.1136/thoraxjnl-2011-201518

[17]

Perera COPD (2012) 10.3109/15412555.2011.650239

[18]

Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial

Ken M. Kunisaki, Mark T. Dransfield, Julie A. Anderson et al.

American Review of Respiratory Disease 2018 10.1164/rccm.201711-2239oc

[19]

Hu BMC Cardiovasc Disord (2020) 10.1186/s12872-020-01803-8

[20]

Goto J Gen Intern Med (2018) 10.1007/s11606-018-4518-3

[21]

Swart Respir Res (2023) 10.1186/s12931-023-02601-4

[22]

Nordon BMJ Open (2023) 10.1136/bmjopen-2022-070022

[23]

National Center for Health Statistics. National Death Index User’s Guide. Hyattsville, MD: National Center for Health Statistics; 2013.

[24]

Rogot J Chronic Dis (1986) 10.1016/0021-9681(86)90155-4

[25]

Zhang Ther Adv Respir Dis (2018) 10.1177/1753466618769514

[26]

Schacht Biometrics (2008) 10.1111/j.1541-0420.2008.00994.x

[27]

Stuart J Clin Epidemiol (2013) 10.1016/j.jclinepi.2013.01.013

[28]

U.S. Census Bureau. 2013–2017 American Community Survey 3-year Public Use Microdata Samples. U.S. Census Bureau, ed. guides.library.duq.edu/c.php?g=753544&p=5401552: U.S. Census Bureau; 2012.

[29]

Kostikas Eur Respirat J (2019)

[30]

Huang PeerJ (2020) 10.7717/peerj.10376

[31]

Chaudhary Lung India (2021) 10.4103/lungindia.lungindia_79_21

[32]

Baldomero J COPD Foundation (2022) 10.15326/jcopdf.2022.0303

[33]

Global Initiative for Chronic Obstructive Lung Disease I. Pocket Guide to COPD Diagnosis, Management, and Prevention, a Guide for Health Care Professionals. Global Initiative for Chronic Obstructive Lung Disease, Inc; 2023.

[34]

Hui Singapore Med J (2015) 10.11622/smedj.2015058

[35]

Lipson Am J Respir Crit Care Med (2020) 10.1164/rccm.201911-2207oc

[36]

Chen Chest (2023) 10.1016/j.chest.2022.07.015

[37]

Montero A, Kearney A, Hamel L, Brodie M American’ challenges with health care costs. Kaiser Family Foundation 2022;Health Costs 12; 2022.

[38]

Chen Am J Med Qual (2011) 10.1177/1062860610390352

[39]

Abelson R Higher bills are leading Americans to delay medical care The New York Times 2023;Health; 2023.

[40]

Larsen Am Health Drug Benefits (2022)

[41]

Kerr Lancet Region Health Am (2023) 10.1016/j.lana.2023.100546

Cited By

34

Adherence to single-inhaler triple therapies in middle-aged patients with chronic obstructive pulmonary disease: A group-based trajectory analysis

Hao Liu, Toshiki Fukasawa · 2026

Respiratory Investigation

Changes over time in treatment patterns and health care resource utilization in patients with COPD: Real-World data from a large health maintenance organization

Vered Rosenberg, Roni Yahalom · 2026

Respiratory Medicine

Metrics

34

Citations

41

References

Details

Published: Jan 01, 2024
Vol/Issue: Volume 19
Pages: 225-241
License: View

Authors

AstraZeneca UK Limited, Cambridge, UK

AstraZeneca UK Limited, Cambridge, UK

Cite This Article

Kimberly Daniels, Stephan Lanes, Arlene Tave, et al. (2024). Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. International Journal of Chronic Obstructive Pulmonary Disease, Volume 19, 225-241. https://doi.org/10.2147/copd.s438893

Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study

You May Also Like